Trials that use: Interim analysis / alpha spending
New to this method? Read the tutorial →
11,819 results
- dal-GenEIndependent statistical analysis of Effect of Dalcetrapib vs Placebo on CV Risk in a Genetically Defined Population With a Recent ACS: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration,…
- Dalantercept in Treating Patients With Recurrent Ovarian Epithelial, Fallopian Tube, or Primary Peritoneal Cavity Cancer: Complete Statistical AnalysisIndependent statistical analysis of Dalantercept in Treating Patients With Recurrent Ovarian Epithelial, Fallopian Tube, or Primary Peritoneal Cavity Cancer: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety,…
- Dalteparin for Primary Venous Thromboembolism (VTE) Prophylaxis in Pancreatic Cancer Patients: Complete Statistical AnalysisIndependent statistical analysis of Dalteparin for Primary Venous Thromboembolism (VTE) Prophylaxis in Pancreatic Cancer Patients: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results…
- Damage Control for Duodenal and Combined Duodenal-Pancreatic Injuries: Complete Statistical AnalysisIndependent statistical analysis of Damage Control for Duodenal and Combined Duodenal-Pancreatic Injuries: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT00937118).
- Dapa-CKDIndependent statistical analysis of A Study to Evaluate the Effect of Dapagliflozin on Renal Outcomes and Cardiovascular Mortality in Patients With Chronic Kidney Disease: primary endpoint results, effect estimate with confidence interval,…
- DAPPERIndependent statistical analysis of Depression and Pain Perseverance Through Empowered Recovery Intervention: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT04091347).
- Daptomycin as an Adjuvant Agent in the Treatment of Enterococcal Native Valve Endocarditis.: Complete Statistical AnalysisIndependent statistical analysis of Daptomycin as an Adjuvant Agent in the Treatment of Enterococcal Native Valve Endocarditis.: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on…
- Daptomycin Versus Placebo in Patients With Neutropenia and Fever: Complete Statistical AnalysisIndependent statistical analysis of Daptomycin Versus Placebo in Patients With Neutropenia and Fever: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT01216241).
- DAR-PIAIndependent statistical analysis of DAR-901 TB Booster Vaccine to Prevent TB in Adolescents: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT02712424).
- Daratumumab in Treating Patients With Relapsed or Refractory Acute Myeloid Leukemia or High-Risk Myelodysplastic Syndrome: Complete Statistical AnalysisIndependent statistical analysis of Daratumumab in Treating Patients With Relapsed or Refractory Acute Myeloid Leukemia or High-Risk Myelodysplastic Syndrome: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety,…
- Daratumumab Plus Gemcitabine, Dexamethasone, Cisplatin in pt R/R CD38+ PTCL-NOS, AITL and TFH: Complete Statistical AnalysisIndependent statistical analysis of Daratumumab Plus Gemcitabine, Dexamethasone, Cisplatin in pt R/R CD38+ PTCL-NOS, AITL and TFH: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on…
- Daratumumab Retreatment in Participants With Multiple Myeloma Who Have Been Previously Treated With Daratumumab: Complete Statistical AnalysisIndependent statistical analysis of Daratumumab Retreatment in Participants With Multiple Myeloma Who Have Been Previously Treated With Daratumumab: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based…
- DARE-VVA1Independent statistical analysis of Study of Intravaginal Tamoxifen in PostMenopausal Women With VVA: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT05378269).
- Dasatinib and Bevacizumab in Treating Patients With Recurrent or Progressive High-Grade Glioma or Glioblastoma Multiforme: Complete Statistical AnalysisIndependent statistical analysis of Dasatinib and Bevacizumab in Treating Patients With Recurrent or Progressive High-Grade Glioma or Glioblastoma Multiforme: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety,…
- Dasatinib in Advanced Non-small Cell Lung Cancer (NSCL) With Ex Vivo and In Vivo Assessment of Tumor Target Modulation: Complete Statistical AnalysisIndependent statistical analysis of Dasatinib in Advanced Non-small Cell Lung Cancer (NSCL) With Ex Vivo and In Vivo Assessment of Tumor Target Modulation: primary endpoint results, effect estimate with confidence interval, sample-size…
- Dasatinib in Treating Patients With Locally Advanced or Metastatic Mucosal Melanoma, Acral Melanoma, or Vulvovaginal Melanoma That Cannot Be Removed By Surgery: Complete Statistical AnalysisIndependent statistical analysis of Dasatinib in Treating Patients With Locally Advanced or Metastatic Mucosal Melanoma, Acral Melanoma, or Vulvovaginal Melanoma That Cannot Be Removed By Surgery: primary endpoint results, effect estimate with…
- Dasatinib in Treating Patients With Previously Treated Metastatic Colorectal Cancer: Complete Statistical AnalysisIndependent statistical analysis of Dasatinib in Treating Patients With Previously Treated Metastatic Colorectal Cancer: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT00504153).
- Dasatinib in Treating Patients With Recurrent Glioblastoma Multiforme or Gliosarcoma: Complete Statistical AnalysisIndependent statistical analysis of Dasatinib in Treating Patients With Recurrent Glioblastoma Multiforme or Gliosarcoma: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT00423735).
- Dasatinib in Treating Patients With Relapsed Small Cell Lung Cancer: Complete Statistical AnalysisIndependent statistical analysis of Dasatinib in Treating Patients With Relapsed Small Cell Lung Cancer: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT00470054).
- Dasatinib in Treating Patients With Stage IIIB, Stage IV, or Recurrent Non-Small Cell Lung Cancer: Complete Statistical AnalysisIndependent statistical analysis of Dasatinib in Treating Patients With Stage IIIB, Stage IV, or Recurrent Non-Small Cell Lung Cancer: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety,…
- DASH4DIndependent statistical analysis of Dietary Approaches to Stop Hypertension for Diabetes: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT04286555).
- Data Analysis for Drug Repurposing for Effective Alzheimer’s Medicines (DREAM)- Propranolol/Carvedilol Versus Atenolol/Bisoprolol/Sotalol: Complete Statistical AnalysisIndependent statistical analysis of Data Analysis for Drug Repurposing for Effective Alzheimer's Medicines (DREAM)- Propranolol/Carvedilol Versus Atenolol/Bisoprolol/Sotalol: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on…
- DATASIndependent statistical analysis of DATAS: The Dual Chamber & Atrial Tachyarrhythmias Adverse Events Study: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT00157820).
- DATECANelderlyIndependent statistical analysis of Assessing Patient-reported & Patient-related Outcomes in Randomized Cancer Trials for Older Adults: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov…
- DavolIndependent statistical analysis of Comparative Study of Biologic Mesh Versus Repair With Component Separation.: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT01295125).
- DaxibotulinumtoxinA for Injection for the Treatment of Plantar Fasciitis: Complete Statistical AnalysisIndependent statistical analysis of DaxibotulinumtoxinA for Injection for the Treatment of Plantar Fasciitis: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT03825315).
- DAYBREAK-ALZIndependent statistical analysis of A Study of Lanabecestat (LY3314814) in Participants With Mild Alzheimer's Disease Dementia: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov…
- Daytime vs. Delayed Eating Among Obese Individuals: Complete Statistical AnalysisIndependent statistical analysis of Daytime vs. Delayed Eating Among Obese Individuals: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT03354169).
- DBSIndependent statistical analysis of Retrospective, Non-significant Risk, Deep Brain Stimulation (DBS) Care Management Software Feasibility Study: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov…
- DCLP3Independent statistical analysis of The International Diabetes Closed Loop (iDCL) Trial: Clinical Acceptance of the Artificial Pancreas: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on…
- DDAVP in the Reduction of Post-operative Ecchymosis in Rhinoplasty: Complete Statistical AnalysisIndependent statistical analysis of DDAVP in the Reduction of Post-operative Ecchymosis in Rhinoplasty: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT01982760).
- DEARIndependent statistical analysis of Dose Escalation and Remission (DEAR): primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT00652145).
- DEB PilotIndependent statistical analysis of The DEB Pilot Study: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT03190993).
- DEBDOXIndependent statistical analysis of Doxorubicin-eluting LC Bead M1 for Patients With Hepatocellular Carcinoma: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT02007954).
- DEBRAIndependent statistical analysis of Investigating the Causal Role of Prefrontal Control in Decision-making in Patients With Anhedonia: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on…
- DECAPUBIndependent statistical analysis of Efficacy and Safety Study of Pamoate of Triptorelin in Children With Precocious Puberty: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on…
- DECIFERIndependent statistical analysis of DECIFER: Depression and Citalopram In First Episode Recovery: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT01041274).
- Decision Aid for Therapeutic Options In Sickle Cell Disease: Complete Statistical AnalysisIndependent statistical analysis of Decision Aid for Therapeutic Options In Sickle Cell Disease: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT02326597).
- Decision Support for Smoking Cessation in Young Adults With Severe Mental Illness: Complete Statistical AnalysisIndependent statistical analysis of Decision Support for Smoking Cessation in Young Adults With Severe Mental Illness: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov…
- Decision-aid on Breast Cancer Screening: Complete Statistical AnalysisIndependent statistical analysis of Decision-aid on Breast Cancer Screening: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT03097653).
- Decitabine and Clofarabine in Higher Risk Myelodysplastic Syndromes (MDS): Complete Statistical AnalysisIndependent statistical analysis of Decitabine and Clofarabine in Higher Risk Myelodysplastic Syndromes (MDS): primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT00903760).
- Decitabine and Gemtuzumab Ozogamicin in Acute Myelogenous Leukemia and High-risk Myelodysplastic Syndrome: Complete Statistical AnalysisIndependent statistical analysis of Decitabine and Gemtuzumab Ozogamicin in Acute Myelogenous Leukemia and High-risk Myelodysplastic Syndrome: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov…
- Decitabine and Tretinoin in Treating Patients With Myelodysplastic Syndromes: Complete Statistical AnalysisIndependent statistical analysis of Decitabine and Tretinoin in Treating Patients With Myelodysplastic Syndromes: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT00382200).
- Decitabine Followed by Idarubicin and Cytarabine in Treating Patients With Relapsed or Refractory AML and MDS: Complete Statistical AnalysisIndependent statistical analysis of Decitabine Followed by Idarubicin and Cytarabine in Treating Patients With Relapsed or Refractory AML and MDS: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and…
- DECLARE-TIMI58Independent statistical analysis of Multicenter Trial to Evaluate the Effect of Dapagliflozin on the Incidence of Cardiovascular Events: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based…
- DECOIndependent statistical analysis of Open-Label Study of Intravitreal ICON-1 in Patients With Choroidal Neovascularization Secondary to Age-related Macular Degeneration (AMD): primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and…
- Deep Brain Stimulation for Major Depressive Disorder: Complete Statistical AnalysisIndependent statistical analysis of Deep Brain Stimulation for Major Depressive Disorder: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT00617162).
- DEEPCOLIndependent statistical analysis of The Effect of Deep Neuromuscular Block on Surgical Condition During Laparoscopic Colorectal Surgery: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on…
- DEFEAT-HFIndependent statistical analysis of Determining the Feasibility of Spinal Cord Neuromodulation for the Treatment of Chronic Heart Failure: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based…
- DEFEAT-PEIndependent statistical analysis of Detect Fluid Early From Intra-thoracic Impedance Monitoring: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT00916929).